Perth-headquartered global bio-nanotech company pSivida Ltd has announced results of trials by Bausch & Lomb to evaluate pSivida Ltd's RetisertTM implant for the treatment of diabetes related eye damage.
03/04/2006 - 11:09
pSivida trials have positive results for diabetic eye disease
03/04/2006 - 11:09